Symmetrical kinetic parameters for 3-O-methyl-D-glucose transport in adipocytes in the presence and in the absence of insulin. 1981

L P Taylor, and G D Holman

3-O-Methyl-D-glucose transport in isolated adipocytes in the presence of insulin is symmetric in zero-trans experiments (transport into sugar-free solutions). K oi zt = 6.10 +/- 1. 65 mM, V oi zt = 1.20 +/- 0.19 mM/s; K io zt = 2.66 +/- 0.26 mM, V io zt = 1.19 +/- 0.07 mM/s. (The superscripts o and i and subscript zt refer to outside, inside and zero-trans conditions, respectively). In the absence of insulin K oi zt = 5.41 +/ 0.98 mM, V oi zt = 0.034 +/- 0.014 mM/s; K io zt = 4.09 +/- 1.05 mM, V io zt = 0.153 +/- 0.023 mM/s. For insulin pre-treated cells, infinite-cis experiments (transport into solutions of varying sugar concentrations) are also symmetric K oi ic = 6.51 +/- 0.83 mM, V oi ic = 0.09 mM/s; K io ic = 3.60 +/- 1.33 mM, V io ic = 1.76 +/- 0.63 mM/S (the subscript ic refers to the infinite-cis condition). In the absence of insulin, K oi ic = 9.03 +/- 3.28 mM, V oi ic = 0.066 +/- mM/s; K io ic = 4.54 +/- 1.32 mM, V io ic = 0.106 +/- 0.026 mM/s. The infinite-cis parameters are shown to be technically easier to measure than the zero-trans parameters. The uses of integrated rate equations for studying rapid transport are demonstrated. The results show that the adipocyte sugar transport system handles 3-O-methyl-D-glucose symmetrically, and that insulin does not change either the internal or the external affinity constants for this glucose analogue.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008757 Methylglucosides Methylglucopyranosides
D008759 Methylglycosides
D002462 Cell Membrane The lipid- and protein-containing, selectively permeable membrane that surrounds the cytoplasm in prokaryotic and eukaryotic cells. Plasma Membrane,Cytoplasmic Membrane,Cell Membranes,Cytoplasmic Membranes,Membrane, Cell,Membrane, Cytoplasmic,Membrane, Plasma,Membranes, Cell,Membranes, Cytoplasmic,Membranes, Plasma,Plasma Membranes
D000273 Adipose Tissue Specialized connective tissue composed of fat cells (ADIPOCYTES). It is the site of stored FATS, usually in the form of TRIGLYCERIDES. In mammals, there are two types of adipose tissue, the WHITE FAT and the BROWN FAT. Their relative distributions vary in different species with most adipose tissue being white. Fatty Tissue,Body Fat,Fat Pad,Fat Pads,Pad, Fat,Pads, Fat,Tissue, Adipose,Tissue, Fatty
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001693 Biological Transport, Active The movement of materials across cell membranes and epithelial layers against an electrochemical gradient, requiring the expenditure of metabolic energy. Active Transport,Uphill Transport,Active Biological Transport,Biologic Transport, Active,Transport, Active Biological,Active Biologic Transport,Transport, Active,Transport, Active Biologic,Transport, Uphill
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus
D019325 3-O-Methylglucose A non-metabolizable glucose analogue that is not phosphorylated by hexokinase. 3-O-Methylglucose is used as a marker to assess glucose transport by evaluating its uptake within various cells and organ systems. (J Neurochem 1993;60(4):1498-504) 3-O-Methyl-D-Glucose,3 O Methyl D Glucose,3 O Methylglucose

Related Publications

L P Taylor, and G D Holman
June 1979, The Journal of biological chemistry,
L P Taylor, and G D Holman
December 1986, The American journal of physiology,
L P Taylor, and G D Holman
October 1971, Journal of clinical pathology,
L P Taylor, and G D Holman
August 1986, Journal of developmental physiology,
L P Taylor, and G D Holman
May 1976, Biochimica et biophysica acta,
L P Taylor, and G D Holman
April 1987, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
L P Taylor, and G D Holman
March 1969, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
L P Taylor, and G D Holman
January 1973, Pflugers Archiv : European journal of physiology,
L P Taylor, and G D Holman
August 1979, The Biochemical journal,
Copied contents to your clipboard!